REGULATION-TECH Senate SponsorsSen. David Koehler House Sponsors(Rep. Kevin John Olickal, Dave Vella, Ryan Spain, Dan Caulkins, Kelly M. Cassidy, Ann M. Williams, Margaret Croke and Will Guzzardi) 1/7/2025SenateSession Sine Die 205 ILCS 5/1from Ch. 17, par. 301Amends the Illinois Banking Act. Makes a technical change in a Section concerning the short title.Senate Floor Amendment No. 2 Deletes reference to:205 ILCS 5/1Adds reference to:215 ILCS 5/513b7 newReplaces everything after the enacting clause. Amends the Pharmacy Benefit Managers Article of the Illinois Insurance Code. Provides that when conducting a pharmacy audit, an auditing entity shall comply with specified requirements. Provides that an auditing entity conducting a pharmacy audit may have access to a pharmacy's previous audit report only if the report was prepared by that auditing entity. Provides that information collected during a pharmacy audit shall be confidential by law, except that the auditing entity conducting the pharmacy audit may share the information with the health benefit plan for which a pharmacy audit is being conducted and with any regulatory agencies and law enforcement agencies as required by law. Provides that a pharmacy may not be subject to a chargeback or recoupment for a clerical or recordkeeping error in a required document or record unless the pharmacy benefit manager can provide proof of intent to commit fraud or such error results in actual financial harm to the pharmacy benefit manager, a health plan managed by the pharmacy benefit manager, or a consumer. Provides that a pharmacy shall have the right to file a written appeal of a preliminary and final pharmacy audit report in accordance with the procedures established by the entity conducting the pharmacy audit. Provides that no interest shall accrue for any party during the audit period. Provides that an auditing entity must provide a copy to the plan sponsor of its claims that were included in the audit, and any recouped money shall be returned to the plan sponsor, unless otherwise contractually agreed upon by the plan sponsor and the pharmacy benefit manager. Defines terms. 2/2/2023SenateFiled with Secretary by Sen. Don Harmon 2/2/2023SenateFirst Reading 2/2/2023SenateReferred to Assignments 3/2/2023SenateAssigned to Executive 3/9/2023SenateDo Pass Executive; 011-000-000 3/9/2023SenatePlaced on Calendar Order of 2nd Reading March 10, 2023 3/10/2023SenateSecond Reading 3/10/2023SenatePlaced on Calendar Order of 3rd Reading March 21, 2023 3/21/2023SenateSenate Floor Amendment No. 1 Filed with Secretary by Sen. David Koehler 3/21/2023SenateSenate Floor Amendment No. 1 Referred to Assignments 3/22/2023SenateSenate Floor Amendment No. 1 Assignments Refers to Insurance 3/22/2023SenateChief Sponsor Changed to Sen. David Koehler 3/24/2023SenateSenate Floor Amendment No. 2 Filed with Secretary by Sen. David Koehler 3/24/2023SenateSenate Floor Amendment No. 2 Referred to Assignments 3/28/2023SenateSenate Floor Amendment No. 2 Assignments Refers to Insurance 3/29/2023SenateSenate Floor Amendment No. 1 Recommend Do Adopt Insurance; 009-000-000 3/29/2023SenateSenate Floor Amendment No. 2 Recommend Do Adopt Insurance; 009-000-000 3/30/2023SenateRecalled to Second Reading 3/30/2023SenateSenate Floor Amendment No. 1 Withdrawn by Sen. David Koehler 3/30/2023SenateSenate Floor Amendment No. 2 Adopted; Koehler 3/30/2023SenatePlaced on Calendar Order of 3rd Reading 3/30/2023SenateThird Reading - Passed; 056-000-000 3/31/2023HouseArrived in House 3/31/2023HouseChief House Sponsor Rep. Emanuel "Chris" Welch 3/31/2023HouseAlternate Chief Sponsor Removed Rep. Emanuel "Chris" Welch 4/11/2023HouseFirst Reading 4/11/2023HouseReferred to Rules Committee 4/21/2023HouseChief House Sponsor Rep. Hoan Huynh 4/21/2023HouseAlternate Chief Sponsor Removed Rep. Hoan Huynh 4/21/2023HouseChief House Sponsor Rep. Kevin John Olickal 4/25/2023HouseAssigned to Prescription Drug Affordability & Accessibility Committee 4/25/2023HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Kevin John Olickal 4/25/2023HouseHouse Committee Amendment No. 1 Referred to Rules Committee 4/25/2023HouseCommittee/Final Action Deadline Extended-9(b) May 19, 2023 4/25/2023HouseAdded Alternate Co-Sponsor Rep. Dave Vella 5/1/2023HouseAdded Alternate Co-Sponsor Rep. Ryan Spain 5/2/2023HouseHouse Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee 5/16/2023HouseAdded Alternate Co-Sponsor Rep. Dan Caulkins 5/16/2023HouseAdded Alternate Co-Sponsor Rep. Kelly M. Cassidy 5/16/2023HouseAdded Alternate Co-Sponsor Rep. Ann M. Williams 5/16/2023HouseAdded Alternate Co-Sponsor Rep. Margaret Croke 5/16/2023HouseAdded Alternate Co-Sponsor Rep. Will Guzzardi 5/19/2023HouseRule 19(a) / Re-referred to Rules Committee 5/19/2023HouseHouse Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee 1/7/2025SenateSession Sine Die